Contrast-Enhanced Ultrasound in Predicting Treatment Response in Patients With Kidney Cancer Undergoing Cryosurgery

NCT02671552 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Terminated by the IRB

Conditions

Renal Cell Carcinoma

Interventions

DRUG: Perflutren Protein-Type A Microspheres
PROCEDURE: Dynamic Contrast-Enhanced Ultrasound Imaging

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University